For the quarter ending 2026-03-31, TXMD has $37,581K in assets. $10,608K in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 8,419 | 7,483 | 7,115 | 6,069 |
| Royalty receivable, current portion | 3,211 | 3,525 | 3,665 | 3,743 |
| Prepaid and other current assets | 3,633 | 3,437 | 3,723 | 3,649 |
| Total current assets | 15,263 | 14,445 | 14,503 | 13,461 |
| License rights and other intangible assets, net | 3,667 | 3,761 | 3,914 | 4,043 |
| Right of use assets, net | 5,062 | 5,293 | 5,515 | 5,732 |
| Royalty receivable, long term | 13,170 | 13,713 | 14,269 | 14,840 |
| Other non-current assets | 419 | 444 | 470 | 428 |
| Total assets | 37,581 | 37,656 | 38,671 | 38,504 |
| Accounts payable | 15 | 377 | 263 | 350 |
| Accrued expenses and other current liabilities | 2,229 | 1,741 | 2,015 | 1,590 |
| Current liabilities of discontinued operations | 2,667 | 2,667 | 2,667 | 2,722 |
| Total current liabilities | 4,911 | 4,785 | 4,945 | 4,662 |
| Operating lease liabilities | 4,824 | 5,122 | 5,411 | 5,718 |
| Other non-current liabilities | 873 | 873 | 871 | 832 |
| Total liabilities | 10,608 | 10,780 | 11,227 | 11,212 |
| Common stock, par value 0.001 640,000 and 32,000 shares authorized, 11,574 and 11,574 issued and outstanding as of march 31,2026 and december 31, 2025, respectively | 11 | 11 | 11 | 11 |
| Additional paid-in capital | 979,258 | 979,256 | 979,205 | 979,205 |
| Accumulated deficit | -952,296 | -952,391 | -951,772 | -951,924 |
| Total stockholders equity | 26,973 | 26,876 | 27,444 | 27,292 |
| Total liabilities and stockholders equity | 37,581 | 37,656 | 38,671 | 38,504 |
TherapeuticsMD, Inc. (TXMD)
TherapeuticsMD, Inc. (TXMD)